[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @OzmosiHealth Ozmosi Ozmosi posts on X about more info, $kymr, kymera, $fate the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::1055982930/interactions)  - X Week XXXXXX +92% - X Month XXXXXXX -XX% - X Months XXXXXXX +63% - X Year XXXXXXXXX +37% ### Mentions: XXX [#](/creator/twitter::1055982930/posts_active)  - X Week XXX +6.80% - X Month XXX -XX% - X Months XXXXX +25% - X Year XXXXX +8.90% ### Followers: XXXXX [#](/creator/twitter::1055982930/followers)  - X Week XXXXX +2% - X Month XXXXX +3.50% - X Months XXXXX +29% - X Year XXXXX +48% ### CreatorRank: XXXXXXX [#](/creator/twitter::1055982930/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) XXXX% [cryptocurrencies](/list/cryptocurrencies) X% [countries](/list/countries) XXX% [currencies](/list/currencies) XXX% [technology brands](/list/technology-brands) XXX% **Social topic influence** [more info](/topic/more-info) #130, [$kymr](/topic/$kymr) #30, [kymera](/topic/kymera) #10, [$fate](/topic/$fate) #1, [$abbv](/topic/$abbv) #56, [$rhhby](/topic/$rhhby) #4, [$biib](/topic/$biib) #11, [$gmab](/topic/$gmab) #3, [$gern](/topic/$gern) #2, [$tern](/topic/$tern) #9 **Top accounts mentioned or mentioned by** [@saylor_monty](/creator/undefined) [@kdamokles](/creator/undefined) **Top assets mentioned** [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [AbbVie Inc (ABBV)](/topic/$abbv) [Biogen Inc (BIIB)](/topic/$biib) [Geron Corp (GERN)](/topic/$gern) [Terns Pharmaceuticals, Inc. Common Stock (TERN)](/topic/$tern) [CG Oncology, Inc. Common stock (CGON)](/topic/$cgon) [AstraZeneca PLC (AZN)](/topic/$azn) [Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)](/topic/$rxrx) [Cogent Biosciences, Inc. Common Stock (COGT)](/topic/$cogt) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Neumora Therapeutics, Inc. Common Stock (NMRA)](/topic/$nmra) [Taraxa (TARA)](/topic/$tara) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/dyne-therapeutics) [Incyte Corporation (INCY)](/topic/$incy) [Arcellx, Inc. Common Stock (ACLX)](/topic/$aclx) [Nuvalent, Inc. Class A Common Stock (NUVL)](/topic/$nuvl) [Dawn Protocol (DAWN)](/topic/$dawn) [One Cash (ONC)](/topic/$onc) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Disc Medicine, Inc. Common Stock (IRON)](/topic/$iron) [Arvinas, Inc (ARVN)](/topic/$arvn) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Eli Lilly and Company (LLY)](/topic/$lly) [Frontline Ltd. (FRO)](/topic/$fro) [BOLT Token (BOLT)](/topic/$bolt) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Celldex Therapeutics, Inc (CLDX)](/topic/$cldx) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [LYRA (LYRA)](/topic/$lyra) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Natera, Inc. Common Stock (NTRA)](/topic/$ntra) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) ### Top Social Posts Top posts by engagements in the last XX hours "$PHGE -XXXXX% today as BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048625738342473) 2025-12-08T15:14Z 3009 followers, XXX engagements "$COYA +1.89% today as Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA XXX for the Treatment of ALS More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422006534930618) 2025-12-09T15:58Z 3011 followers, XX engagements "$ENVB +2.04% today as Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422011421282557) 2025-12-09T15:58Z 3011 followers, XXX engagements "$APVO -XXXX% today as Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422025396682822) 2025-12-09T15:58Z 3011 followers, XXX engagements "$PDSB +17.13% today as PDS Biotech Announces New Composition of Matter Patent for PDS0101 in Japan More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422043042128229) 2025-12-09T15:58Z 3011 followers, XXX engagements "$RHHBY Hoffmann-La Roche presented P3 Follicular Lymphoma results on 2025-12-08 for Mosunetuzumab More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460152890916973) 2025-12-09T18:30Z 3011 followers, XX engagements "$KYMR Kymera Therapeutics presented P1 Dermatitis Atopic results on 2025-12-08 for KT-621 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460165880795373) 2025-12-09T18:30Z 3011 followers, XX engagements "$GPCR Structure Therapeutics presented P2 Obesity results on 2025-12-08 for Aleniglipron More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460187615633575) 2025-12-09T18:30Z 3011 followers, XXX engagements "$OSTX +2.08% today as OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent Fully Resected Pulmonary Metastatic Osteosarcoma More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422079197057358) 2025-12-09T15:58Z 3011 followers, XXX engagements "$FATE Fate presented P1 Lupus Erythematosus Systemic results on 2025-12-08 for FT-819 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460131671937379) 2025-12-09T18:29Z 3011 followers, XX engagements "$CASI CASI presented P1 Thrombocytopenia results on 2025-12-08 for CID-103 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503176673055107) 2025-12-09T21:21Z 3011 followers, XX engagements "$RXRX Recursion Pharmaceuticals presented P2 Familial Adenomatous Polyposis results on 2025-12-08 for REC-4881 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503283787170222) 2025-12-09T21:21Z 3011 followers, XXX engagements "$RGNX Regenxbio announced they will present P3 Muscular Dystrophy Duchenne results in 2Q26 for Pivodisgene parvec More Info:" [X Link](https://x.com/OzmosiHealth/status/1986910316928606288) 2025-11-07T21:35Z 3010 followers, XXX engagements "$RGNX Regenxbio announced they will present P3 Wet Macular Degeneration results in 4Q26 for Surabgene Lomparvovec More Info:" [X Link](https://x.com/OzmosiHealth/status/1986910324272881832) 2025-11-07T21:35Z 3010 followers, XXX engagements "$BOLT Bolt Biotherapeutics announced they will present P1 AdenocarcinomaGastrointestinal CancerEsophageal Cancer results in 3Q26 for BDC-4182 More Info:" [X Link](https://x.com/OzmosiHealth/status/1989046889254170808) 2025-11-13T19:05Z 3009 followers, XXX engagements "$4523 as Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status More Info:" [X Link](https://x.com/OzmosiHealth/status/1993332521589678547) 2025-11-25T14:54Z 3009 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $LEGN Legend Biotech will present Phase X Lymphoma Non-Hodgkin Data for Ciltacabtagene autoleucel (CAR-TBCMA - Autologous CAR-T) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900475560714375) 2025-12-05T11:12Z 3009 followers, XXX engagements "$AGIO +0.87% today as Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048681417703520) 2025-12-08T15:15Z 3011 followers, XXX engagements "$HRMY -XXXX% today as Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048700480790602) 2025-12-08T15:15Z 3011 followers, XXX engagements "$ATOS +2.76% today as Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422016311910719) 2025-12-09T15:58Z 3011 followers, XXX engagements "$AKTX -XXXX% today as Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate AKTX-101 for Hard-to-Treat K-Ras Mutant Pancreatic Cancer More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422030165700991) 2025-12-09T15:58Z 3011 followers, XXX engagements "$PTIX -XXXX% today as Results from Phase X Multiple-Dose Study of PT00114 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422034431258824) 2025-12-09T15:58Z 3011 followers, XX engagements "$SNTI -XXXX% today as Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase X Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients Demonstrating Deep MRD Negative Durable Complete Remissions and a Favorable Safety Profile More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422052479328497) 2025-12-09T15:58Z 3011 followers, XXX engagements "$ENSC -XXXXX% today as Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase X Trial of PF614 Its Next-Generation Opioid More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422069881532634) 2025-12-09T15:58Z 3011 followers, XXX engagements "$KYMR Kymera Therapeutics announced they will present P2 Dermatitis Atopic results in 3Q27 for KT-621 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460085165601085) 2025-12-09T18:29Z 3011 followers, XX engagements "$DYN Dyne Therapeutics presented P1 Muscular Dystrophy Duchenne results on 2025-12-08 for Zeleciment rostudirsen More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460118560612790) 2025-12-09T18:29Z 3011 followers, XXX engagements "$FATE Fate presented P0 Autoimmune Disease Unspecified results on 2025-12-08 for FT-839 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460123249840330) 2025-12-09T18:29Z 3011 followers, XX engagements "$FATE Fate presented P0 Multiple Myeloma results on 2025-12-08 for FT-836 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460127549047291) 2025-12-09T18:29Z 3011 followers, XXX engagements "$GMAB Genmab presented P1 Chronic Lymphoid Leukemia results on 2025-12-08 for Epcoritamab More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460140006084778) 2025-12-09T18:30Z 3011 followers, XX engagements "$RHHBY Hoffmann-La Roche presented P3 Diffuse Large B-Cell Lymphoma results on 2025-12-08 for Glofitamab More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460148336013480) 2025-12-09T18:30Z 3011 followers, XX engagements "$IVBIY Innovent presented P3 Psoriasis results on 2025-12-08 for Picankibart More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460160998576553) 2025-12-09T18:30Z 3011 followers, XX engagements "$MNOV MediciNova presented P2 Amyotrophic Lateral Sclerosis results on 2025-12-08 for Ibudilast More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460170003685832) 2025-12-09T18:30Z 3011 followers, XX engagements "$PRAX -XXXX% today as Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic Encephalopathy More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503101368574272) 2025-12-09T21:20Z 3011 followers, XXX engagements "$GLMD Galmed announced they will present P1 Hepatocellular Carcinoma results on 2025-12-09 for Aramchol More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503147296206950) 2025-12-09T21:20Z 3011 followers, XXX engagements "$AUTL Autolus Limited presented P1 Acute LeukemiaB-Cell Leukemia results on 2025-12-08 for Obecabtagene autoleucel More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503170981400608) 2025-12-09T21:21Z 3011 followers, XXX engagements "$COGT Cogent Biosciences presented P2 Mastocytosis Systemic results on 2025-12-08 for Bezuclastinib More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503182096372223) 2025-12-09T21:21Z 3011 followers, XXX engagements "$FATE Fate presented P0 Multiple Myeloma results on 2025-12-08 for FT-836 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503209548001495) 2025-12-09T21:21Z 3011 followers, XX engagements "$FATE Fate presented P1 Lupus Erythematosus Systemic results on 2025-12-08 for FT-819 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503219421458796) 2025-12-09T21:21Z 3011 followers, XXX engagements "$GLPG Galapagos presented P2 Mantle-Cell Lymphoma results on 2025-12-08 for GLPG-5101 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503225478009022) 2025-12-09T21:21Z 3011 followers, XX engagements "$GMAB Genmab presented P1 Chronic Lymphoid Leukemia results on 2025-12-08 for Epcoritamab More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503230544748892) 2025-12-09T21:21Z 3011 followers, XX engagements "$INCY Incyte presented P1 Myeloproliferative Disorders results on 2025-12-08 for INCA-033989 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503256318779903) 2025-12-09T21:21Z 3011 followers, XX engagements "$KYMR Kymera Therapeutics presented P1 Dermatitis Atopic results on 2025-12-08 for KT-621 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503267349721533) 2025-12-09T21:21Z 3011 followers, XX engagements "$MNOV MediciNova presented P2 Amyotrophic Lateral Sclerosis results on 2025-12-08 for Ibudilast More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503272882053507) 2025-12-09T21:21Z 3011 followers, XX engagements "$NRIX Nurix Therapeutics presented P1 Waldenstrom Macroglobulinemia results on 2025-12-08 for Bexobrutideg More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503278078738856) 2025-12-09T21:21Z 3011 followers, XXX engagements "$GPCR Structure Therapeutics presented P2 Obesity results on 2025-12-08 for Aleniglipron More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503295229260039) 2025-12-09T21:21Z 3011 followers, XXX engagements "$SNDX Syndax presented P2 Acute Myeloid Leukemia results on 2025-12-08 for Revumenib More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503301571060036) 2025-12-09T21:21Z 3011 followers, XXX engagements "$FATE -XXXX% today as Fate Therapeutics Presents Updated Phase X Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048637318799404) 2025-12-08T15:14Z 3011 followers, XXX engagements "$GERN +1.90% today as Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO (Imetelstat) in Lower-Risk MDS More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048733355811085) 2025-12-08T15:15Z 3011 followers, XXX engagements "$CHRS +8.16% today as Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048739924013193) 2025-12-08T15:15Z 3011 followers, XXX engagements "$CRDF +10.61% today as Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141281554293084) 2025-12-08T21:22Z 3009 followers, XXX engagements "$CLDX -XXXX% today as Celldex Initiates Global Registrational Phase X Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422020934062557) 2025-12-09T15:58Z 3009 followers, XX engagements "$BMY -XXXX% today as BioNTech and Bristol Myers Squibb Present First Global Phase X Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422038482956758) 2025-12-09T15:58Z 3011 followers, XXX engagements "$SNTI -XXXX% today as Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422057508393150) 2025-12-09T15:58Z 3011 followers, XXX engagements "$AUTL Autolus Limited presented P1 Acute LeukemiaB-Cell Leukemia results on 2025-12-08 for Obecabtagene autoleucel More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460097610080618) 2025-12-09T18:29Z 3011 followers, XXX engagements "$CRVS Corvus presented P1 T-Cell Lymphoma results on 2025-12-08 for Soquelitinib More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460110301970435) 2025-12-09T18:29Z 3011 followers, XXX engagements "$CGEM Cullinan Oncology presented P1 Acute Myeloid LeukemiaMyelodysplastic Syndrome results on 2025-12-08 for CLN-049 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460114458558903) 2025-12-09T18:29Z 3011 followers, XXX engagements "$GLPG Galapagos presented P2 Mantle-Cell Lymphoma results on 2025-12-08 for GLPG-5101 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460136000491890) 2025-12-09T18:30Z 3011 followers, XX engagements "$INCY Incyte presented P1 Myeloproliferative Disorders results on 2025-12-08 for INCA-033989 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460156925837752) 2025-12-09T18:30Z 3011 followers, XX engagements "$NRIX Nurix Therapeutics presented P1 Waldenstrom Macroglobulinemia results on 2025-12-08 for Bexobrutideg More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460174005100749) 2025-12-09T18:30Z 3011 followers, XX engagements "$SABS SAb Biotherapeutics presented P1 Type X Diabetes results on 2025-12-08 for SAB-142 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460183077400939) 2025-12-09T18:30Z 3011 followers, XX engagements "$SNDX Syndax presented P2 Acute Myeloid Leukemia results on 2025-12-08 for Revumenib More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460191864406452) 2025-12-09T18:30Z 3011 followers, XXX engagements "$TERN Terns presented P1 Chronic Myeloid Leukemia results on 2025-12-08 for TERN-701 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460195928781092) 2025-12-09T18:30Z 3009 followers, XXX engagements "$WVE Wave Life Sciences presented P1 Obesity results on 2025-12-08 for INHBE More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460208297722239) 2025-12-09T18:30Z 3009 followers, XXX engagements "$CRVS Corvus presented P1 T-Cell Lymphoma results on 2025-12-08 for Soquelitinib More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503188446507194) 2025-12-09T21:21Z 3011 followers, XXX engagements "$CGEM Cullinan Oncology presented P1 Acute Myeloid LeukemiaMyelodysplastic Syndrome results on 2025-12-08 for CLN-049 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503193542590622) 2025-12-09T21:21Z 3011 followers, XX engagements "$FATE Fate presented P0 Autoimmune Disease Unspecified results on 2025-12-08 for FT-839 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503204015788518) 2025-12-09T21:21Z 3011 followers, XX engagements "$GERN Geron presented P3 Myelodysplastic Syndrome results on 2025-12-08 for Imetelstat More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503236261564831) 2025-12-09T21:21Z 3011 followers, XX engagements "$IVBIY Innovent presented P3 Psoriasis results on 2025-12-08 for Picankibart More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503262157193701) 2025-12-09T21:21Z 3011 followers, XX engagements "$SABS SAb Biotherapeutics presented P1 Type X Diabetes results on 2025-12-08 for SAB-142 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503288925253686) 2025-12-09T21:21Z 3011 followers, XXX engagements "$TERN Terns presented P1 Chronic Myeloid Leukemia results on 2025-12-08 for TERN-701 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503307774460093) 2025-12-09T21:21Z 3011 followers, XXX engagements "$BNR +1.06% today as Burning Rock's OncoGuide OncoScreen Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer More Info:" [X Link](https://x.com/OzmosiHealth/status/1970849116151308649) 2025-09-24T13:53Z 2990 followers, XXX engagements "$LYRA Lyra Therapeutics announced they will present Phase X Sinusitis results on 2025-10-13 for Mometasone furoate More Info:" [X Link](https://x.com/OzmosiHealth/status/1975742079666889189) 2025-10-08T01:56Z 3004 followers, XXX engagements "$FBIO -XXXX% today as Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics' Global Phase X Trials of Dotinurad for the Treatment of Gout More Info:" [X Link](https://x.com/OzmosiHealth/status/1980634660045554138) 2025-10-21T13:57Z 2984 followers, XXX engagements "$ZLAB -XXXX% today as Zai Lab Announces Updated Phase X Data for Zocilurtatug Pelitecan (formerly ZL-1310) Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer and Initiation of Global Phase X Registrational Study More Info:" [X Link](https://x.com/OzmosiHealth/status/1981724631749829079) 2025-10-24T14:09Z 3011 followers, XXX engagements "$IMAB I-Mab Biopharma presented P1 Gastrointestinal Cancer results on 2025-10-23 for Givastomig More Info:" [X Link](https://x.com/OzmosiHealth/status/1981724747701289121) 2025-10-24T14:09Z 3012 followers, XXX engagements "$ARGX argenx announced they will present P2 Amyotrophic Lateral Sclerosis results in 1H26 for Adimanebart More Info:" [X Link](https://x.com/OzmosiHealth/status/1985363697863151845) 2025-11-03T15:09Z 2984 followers, XXX engagements "$ARGX argenx announced they will present P3 Sjogren's Syndrome results in YE27 for Efgartigimod More Info:" [X Link](https://x.com/OzmosiHealth/status/1985363705312215386) 2025-11-03T15:09Z 2985 followers, XXX engagements "$ACLX Arcellx announced they will present P2 Multiple Myeloma results on 2025-12-06 for Anitocabtagene autoleucel More Info:" [X Link](https://x.com/OzmosiHealth/status/1985813243965714473) 2025-11-04T20:55Z 2998 followers, XXX engagements "$MLTX +3.95% today as MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody Sonelokimab More Info:" [X Link](https://x.com/OzmosiHealth/status/1986098868216369659) 2025-11-05T15:50Z 2984 followers, XXX engagements "$ARGX -XXXX% today as argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada More Info:" [X Link](https://x.com/OzmosiHealth/status/1986098909567926682) 2025-11-05T15:50Z 2994 followers, XXX engagements "$SCYX Scynexis announced they will present P2 Candidiasis results in YE26 for SCY-247 More Info:" [X Link](https://x.com/OzmosiHealth/status/1986530614439285235) 2025-11-06T20:26Z 2995 followers, XXX engagements "$NMRA Neumora announced they will present P1 Alzheimer Disease results in 4Q25 for NMRA-511 More Info:" [X Link](https://x.com/OzmosiHealth/status/1986910279909757378) 2025-11-07T21:35Z 2994 followers, XXX engagements "$NMRA Neumora announced they will present P1 Schizophrenia results in 4Q25 for NMRA-861 More Info:" [X Link](https://x.com/OzmosiHealth/status/1986910285664297428) 2025-11-07T21:35Z 2988 followers, XXX engagements "$NMRA Neumora announced they will present P3 Depressive Disorder Major results in 1Q26 for Navacaprant More Info:" [X Link](https://x.com/OzmosiHealth/status/1986910291616014641) 2025-11-07T21:35Z 3009 followers, XXX engagements "$ZLAB Zai Lab announced they will present P1 Dermatitis Atopic results in YE26 for ZL-1503 More Info:" [X Link](https://x.com/OzmosiHealth/status/1986910331151532080) 2025-11-07T21:35Z 3007 followers, XXX engagements "$ZLAB Zai Lab announced they will present P1 Small Cell Lung Cancer results in 1H26 for Zocilurtatug pelitecan More Info:" [X Link](https://x.com/OzmosiHealth/status/1986910337614938270) 2025-11-07T21:35Z 2983 followers, XXX engagements "$OTLK +29.95% today as Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD More Info:" [X Link](https://x.com/OzmosiHealth/status/1989000652756766962) 2025-11-13T16:01Z 2985 followers, XXX engagements "$ASND +5.95% today as Results of Pivotal ApproaCH Trial of TransCon CNP (Navepegritide) in Children with Achondroplasia Published in JAMA Pediatrics More Info:" [X Link](https://x.com/OzmosiHealth/status/1990529026360803569) 2025-11-17T21:14Z 2984 followers, XXX engagements "$CGON CG Oncology announced they will present P3 Bladder CancerMuscle Cancer results in 4Q25 for Cretostimogene grenadenorepvec More Info:" [X Link](https://x.com/OzmosiHealth/status/1990529100109230216) 2025-11-17T21:14Z 2988 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $NUVL Nuvalent will present Preclinical Brain CancerNon-Small-Cell Lung CancerOncology Solid Tumor UnspecifiedSmall Cell Lung Cancer Data for NVL-330 (ERBB2 InhibitorTK Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1990739809648951466) 2025-11-18T11:12Z 2985 followers, XXX engagements "$GMAB -XXXX% today as Genmab Announces EPKINLY (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma More Info:" [X Link](https://x.com/OzmosiHealth/status/1990835194832515073) 2025-11-18T17:31Z 3012 followers, XXX engagements "$HRMY -XXXX% today as Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin X Receptor Agonist (BP1.15205) for Central Disorders of Hypersomnolence More Info:" [X Link](https://x.com/OzmosiHealth/status/1991158923273834976) 2025-11-19T14:57Z 2983 followers, XXX engagements "$NBIX +0.55% today as Neurocrine Biosciences Announces Publication of Landmark Narrative Review on FDA-Approved VMAT2 Inhibitors Demonstrating Unique Profile of INGREZZA (valbenazine) Capsules More Info:" [X Link](https://x.com/OzmosiHealth/status/1991517369185767617) 2025-11-20T14:41Z 3011 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $DAWN Day One Biopharmaceuticals will present Phase X Glioma Data for Tovorafenib (RAFk Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1992189371198706091) 2025-11-22T11:12Z 2990 followers, XXX engagements "$DAWN +0.47% today as Day One Announces Three Year Follow-Up Data From OJEMDA (tovorafenib) Phase X FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting More Info:" [X Link](https://x.com/OzmosiHealth/status/1992971051467149616) 2025-11-24T14:58Z 2990 followers, XXX engagements "$KYMR +0.24% today as Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader More Info:" [X Link](https://x.com/OzmosiHealth/status/1993332472394719382) 2025-11-25T14:54Z 2994 followers, XXX engagements "$ANVS Annovis Bio announced they will present P3 Alzheimer Disease results on 2025-12-01 for Buntanetap More Info:" [X Link](https://x.com/OzmosiHealth/status/1993404759013806139) 2025-11-25T19:41Z 2984 followers, XXX engagements "$CGON +4.52% today as CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting More Info:" [X Link](https://x.com/OzmosiHealth/status/1993429620037677506) 2025-11-25T21:20Z 2994 followers, XXX engagements "$ONC +2.05% today as U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma More Info:" [X Link](https://x.com/OzmosiHealth/status/1993698010023219559) 2025-11-26T15:07Z 2995 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $ANVS Annovis Bio will present Phase X Alzheimer Disease Data for Buntanetap (APP Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1995088475465695670) 2025-11-30T11:12Z 3011 followers, XXX engagements "$IONS -XXXX% today as Ionis receives U.S. FDA Breakthrough Therapy designation for olezarsen for severe hypertriglyceridemia (sHTG) More Info:" [X Link](https://x.com/OzmosiHealth/status/1995519788936761802) 2025-12-01T15:46Z 2983 followers, XXX engagements "$HCM HUTCHMED announced they will present P2 Renal Cell Carcinoma results on 2025-12-05 for Fruquintinib More Info:" [X Link](https://x.com/OzmosiHealth/status/1995577382279754188) 2025-12-01T19:34Z 3004 followers, XXX engagements "$HCM HUTCHMED announced they will present P3 ThrombocytopeniaPurpura Thrombocytopenic Idiopathic results on 2025-12-08 for Sovleplenib More Info:" [X Link](https://x.com/OzmosiHealth/status/1995577386448908707) 2025-12-01T19:34Z 3004 followers, XXX engagements "$TARA -XXXX% today as Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase X ADVANCED-2 Trial of TARA-002 in BCG-Nave NMIBC Patients on Wednesday December X 2025 More Info:" [X Link](https://x.com/OzmosiHealth/status/1995617668657733702) 2025-12-01T22:15Z 2994 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $BIIB Biogen will present Phase X Healthy Volunteers Data for IONIS-MAPTRx (Tau Inhibitor - Nucleic Acid) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1995813302249947443) 2025-12-02T11:12Z 3002 followers, XXX engagements "$IONS +0.20% today as Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD) More Info:" [X Link](https://x.com/OzmosiHealth/status/1995875243437556144) 2025-12-02T15:18Z 2983 followers, XXX engagements "$CMND -XXXXX% today as Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder More Info:" [X Link](https://x.com/OzmosiHealth/status/1995875256964170103) 2025-12-02T15:18Z 2983 followers, XXX engagements "$NTRA +1.76% today as Natera to Present XX Datasets Including 50000 Patients Featuring Signatera at the San Antonio Breast Cancer Symposium More Info:" [X Link](https://x.com/OzmosiHealth/status/1995875315164295593) 2025-12-02T15:18Z 2984 followers, XXX engagements "$BIIB Biogen announced they will present P1 Dravet Syndrome results on 2025-12-05 for Zorevunersen More Info:" [X Link](https://x.com/OzmosiHealth/status/1995962687654678995) 2025-12-02T21:06Z 3003 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $TARA Protara Therapeutics will present Phase X Bladder CancerMuscle Cancer Data for TARA-002 (Cell TherapyIL12IL2IL6IL8IL10 - Cell Therapy) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996175637892280563) 2025-12-03T11:12Z 2994 followers, XXX engagements "$ABBV AbbVie announced they will present P1 Multiple Myeloma results on 2025-12-06 for Etentamig More Info:" [X Link](https://x.com/OzmosiHealth/status/1996323390118863044) 2025-12-03T20:59Z 3006 followers, XXX engagements "$ABBV AbbVie announced they will present P2 Acute Myeloid Leukemia results on 2025-12-07 for Pivekimab sunirine More Info:" [X Link](https://x.com/OzmosiHealth/status/1996323396095734175) 2025-12-03T20:59Z 3005 followers, XXX engagements "$ABBV AbbVie announced they will present P3 Myelodysplastic Syndrome results on 2025-12-06 for Venetoclax More Info:" [X Link](https://x.com/OzmosiHealth/status/1996323401934262582) 2025-12-03T20:59Z 3005 followers, XXX engagements "$JAZZ Jazz announced they will present P3 Gastrointestinal Cancer results on 2026-01-09 for Zanidatamab More Info:" [X Link](https://x.com/OzmosiHealth/status/1996323419911061797) 2025-12-03T20:59Z 2983 followers, XXX engagements "$BIIB Biogen presented P3 Alzheimer Disease results on 2025-12-02 for Lecanemab More Info:" [X Link](https://x.com/OzmosiHealth/status/1996323439934652827) 2025-12-03T20:59Z 3002 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $CGON CG Oncology will present Phase X Bladder Cancer Data for Cretostimogene grenadenorepvec (Gene TherapyGM-CSF - Gene Therapy) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996538079918838070) 2025-12-04T11:12Z 3008 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $CGON CG Oncology will present Phase X Bladder Cancer Data for Cretostimogene grenadenorepvec (Gene TherapyGM-CSF - Gene Therapy) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996538080598315273) 2025-12-04T11:12Z 3008 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $HCM HUTCHMED will present Phase X Renal Cell Carcinoma Data for Fruquintinib (VEGFR Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996538081323987054) 2025-12-04T11:12Z 3004 followers, XX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $BIIB Biogen will present Phase X Dravet Syndrome Data for Zorevunersen (Voltage-Gated Sodium Channel Modulator - Nucleic Acid) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996538083664371948) 2025-12-04T11:12Z 3003 followers, XXX engagements "$ENLV +0.91% today as Enlivex Management to Host Fireside Chat on December XX to Discuss RAIN Token Strategy and Allocetra Clinical Development More Info:" [X Link](https://x.com/OzmosiHealth/status/1996596297881555282) 2025-12-04T15:03Z 2984 followers, XXX engagements "$ANVS Annovis Bio announced they will present Unknown Parkinson's Disease results on 2025-12-05 for Buntanetap More Info:" [X Link](https://x.com/OzmosiHealth/status/1996664503321104779) 2025-12-04T19:34Z 2998 followers, XXX engagements "$KURA Kura Oncology announced they will present P3 Acute Myeloid Leukemia results on 2025-12-08 for Ziftomenib More Info:" [X Link](https://x.com/OzmosiHealth/status/1996664510216581435) 2025-12-04T19:34Z 3000 followers, XXX engagements "$TARA Protara Therapeutics presented P2 Bladder CancerMuscle Cancer results on 2025-12-03 for TARA-002 More Info:" [X Link](https://x.com/OzmosiHealth/status/1996664554311258309) 2025-12-04T19:35Z 2994 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $IRON Disc Medicine will present Phase X AnemiaMyelofibrosis Data for DISC-0974 (HJV Antagonist - Antibody) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900468644368780) 2025-12-05T11:12Z 3011 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $IRON Disc Medicine will present Phase X Polycythemia Vera Data for DISC-3405 (TMPRSS6 Antagonist - Antibody) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900469332115505) 2025-12-05T11:12Z 3011 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $ARVN Arvinas will present Preclinical Lymphoma Non-HodgkinLymphoma B-CellT-Cell Peripheral LymphomaImmunoblastic Lymphadenopathy Data for Zaloblideg (BCL6 Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900472104669325) 2025-12-05T11:12Z 2995 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $GMAB Genmab will present Phase X Diffuse Large B-Cell Lymphoma Data for Epcoritamab (CD20 BinderCD3 Binder - Bispecific Antibody) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900472763163042) 2025-12-05T11:12Z 3010 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $ACLX Arcellx will present Phase X Multiple Myeloma Data for Anitocabtagene autoleucel (CAR-TBCMA - Autologous CAR-T) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900473417392325) 2025-12-05T11:12Z 3011 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $GERN Geron will present Phase X Myelodysplastic Syndrome Data for Imetelstat (telomerase Inhibitor - Nucleic Acid) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900476273688721) 2025-12-05T11:12Z 3011 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $BEAM Beam Therapeutics will present Phase X Anemia Sickle Cell Data for BEAM-101 (Gene TherapyCD34 - Gene Therapy) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900478878400854) 2025-12-05T11:12Z 2983 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $NUVL Nuvalent will present Phase X Non-Small-Cell Lung Cancer Data for Zidesamtinib (ROS1 Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900480203805137) 2025-12-05T11:12Z 3011 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $ARVN Arvinas will present Preclinical Diffuse Large B-Cell Lymphoma Data for Zaloblideg (BCL6 Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900480870674802) 2025-12-05T11:12Z 2998 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $REGN Regeneron will present Phase X Paroxysmal Nocturnal Hemoglobinuria Data for Pozelimab (C5 Inhibitor - Antibody) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900482238107674) 2025-12-05T11:12Z 2989 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $REGN Regeneron will present Phase X Diffuse Large B-Cell Lymphoma Data for Odronextamab (CD20 AntagonistCD3 Inhibitor - Bispecific Antibody) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900482892419387) 2025-12-05T11:12Z 2984 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $XENE Xenon will present Phase X Epilepsy Data for Azetukalner (KCNQ2 OpenerKCNQ3 Opener - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900488907051425) 2025-12-05T11:12Z 2985 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $ABBV AbbVie will present Phase X Multiple Myeloma Data for Etentamig (BCMA InhibitorCD3 Inhibitor - Bispecific Antibody) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900490995814519) 2025-12-05T11:12Z 3006 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $ABBV AbbVie will present Phase X Myelodysplastic Syndrome Data for Venetoclax (BCL2 Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1996900491662709072) 2025-12-05T11:12Z 3006 followers, XXX engagements "$INTS Intensity announced they will present P2 Triple Negative Breast Cancer results on 2025-12-12 for INT230-6 More Info:" [X Link](https://x.com/OzmosiHealth/status/1997043218697855385) 2025-12-05T20:39Z 2982 followers, XXX engagements "$PLRX Pliant presented P1 Oncology Solid Tumor Unspecified results on 2025-12-04 for PLN-101095 More Info:" [X Link](https://x.com/OzmosiHealth/status/1997043243507184105) 2025-12-05T20:39Z 3000 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $HCM HUTCHMED will present Phase X Oncology Solid Tumor Unspecified Data for HMPL-A83 (CD47 Inhibitor - Antibody) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1997262816731070609) 2025-12-06T11:12Z 2997 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $AZN AstraZeneca will present Phase X Acute Lymphoid Leukemia Data for Surovatamig (CD19 AntagonistCD3 Inhibitor - Bispecific Antibody) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1997262818715082986) 2025-12-06T11:12Z 2984 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $AZN AstraZeneca will present Phase X Lymphoma Non-Hodgkin Data for Surovatamig (CD19 AntagonistCD3 Inhibitor - Bispecific Antibody) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1997262819449082235) 2025-12-06T11:12Z 2984 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $AZN AstraZeneca will present Phase X Mantle-Cell Lymphoma Data for Acalabrutinib (Btk Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1997262820082438614) 2025-12-06T11:12Z 3000 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $AZN AstraZeneca will present Phase X Oncology Hematological Unspecified Data for AZD-4512 (CD22 Inhibitor - Antibody Drug Conjugate) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1997262820703179038) 2025-12-06T11:12Z 2983 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $TERN Terns will present Phase X Chronic Myeloid Leukemia Data for TERN-701 (Bcr-Abl Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1997625193788043665) 2025-12-07T11:12Z 3003 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $NVS Novartis will present Phase X Purpura Thrombocytopenic Idiopathic Data for Ianalumab (BLyS Inhibitor - Antibody) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1997987627409285139) 2025-12-08T11:12Z 3005 followers, XXX engagements "$PRTC +4.81% today as PureTech Announces Successful End-of-Phase X Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048597447754077) 2025-12-08T15:14Z 3013 followers, XXX engagements "$KYMR +50.38% today as Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048604582211952) 2025-12-08T15:14Z 3011 followers, XXX engagements "$WVE +96.94% today as Wave Life Sciences Announces Positive Interim Data from Phase X INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048611880346048) 2025-12-08T15:14Z 3012 followers, XXX engagements "$RXRX +0.43% today as Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048619098730755) 2025-12-08T15:14Z 3011 followers, XXX engagements "$GPCR +174.36% today as Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist Aleniglipron More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048631341904342) 2025-12-08T15:14Z 3011 followers, XXX engagements "$NRIX +14.15% today as Nurix Therapeutics Presents New Data from the Phase X Trial of Bexobrutideg (NX-5948) in Waldenstrm Macroglobulinemia at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048650530902194) 2025-12-08T15:14Z 3011 followers, XXX engagements "$RHHBY +1.50% today as Roche's Columvi combination shows sustained survival benefit at three-year follow up of pivotal phase III STARGLO study More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048656780411367) 2025-12-08T15:14Z 3008 followers, XXX engagements "$MBRX +4.57% today as Moleculin Announces New Annamycin Collaboration in Brain Tumors More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048662442688762) 2025-12-08T15:14Z 3011 followers, XXX engagements "$CASI -XXXX% today as CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048687423902148) 2025-12-08T15:15Z 3011 followers, XXX engagements "$MRK -XXXX% today as Saskatchewan Adds CAPVAXIVE to Publicly Funded Adult Immunization Program More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048694042529906) 2025-12-08T15:15Z 3011 followers, XXX engagements "$MNOV -XXXX% today as MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048706013151293) 2025-12-08T15:15Z 3011 followers, XXX engagements "$PCVX +1.36% today as Vaxcyte Doses First Participants in the OPUS Phase X Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048712560386157) 2025-12-08T15:15Z 3011 followers, XXX engagements "$ZLAB -XXXX% today as Zai Lab Announces Dosing of First Participant in Global Phase 1/1b study of ZL-1503 an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048719917166996) 2025-12-08T15:15Z 3009 followers, XXX engagements "$SABS -XXXX% today as SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048727127244956) 2025-12-08T15:15Z 3011 followers, XXX engagements "$CGEM +17.66% today as Cullinan Therapeutics Showcases Compelling Clinical Data in AML for CLN-049 Novel FLT3xCD3 T Cell Engager in Oral Presentation at the 67th ASH Meeting More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141276919607707) 2025-12-08T21:22Z 3011 followers, XXX engagements "$CRVS -XXXX% today as Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141285438198096) 2025-12-08T21:23Z 3011 followers, XXX engagements "$TERN +36.70% today as Terns Highlights Additional Positive Phase X Clinical Data Supporting TERN-701's Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141289427034282) 2025-12-08T21:23Z 3011 followers, XXX engagements "$KYMR Kymera Therapeutics announced they will present P1 Dermatitis Atopic results on 2025-12-08 for KT-621 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141316710969741) 2025-12-08T21:23Z 3011 followers, XXX engagements "$BIIB Biogen presented P1 Dravet Syndrome results on 2025-12-05 for Zorevunersen More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141326294942155) 2025-12-08T21:23Z 3011 followers, XXX engagements "$ORIC Oric presented P1 Non-Small-Cell Lung Cancer results on 2025-12-06 for Enozertinib More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141335405011049) 2025-12-08T21:23Z 3011 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $ABBV AbbVie will present Phase X Acute Myeloid Leukemia Data for Pivekimab sunirine (CD123 Inhibitor - Antibody Drug Conjugate) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1997262818010427499) 2025-12-06T11:12Z 3009 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $KURA Kura Oncology will present Phase X Acute Myeloid Leukemia Data for Ziftomenib (MEN1 Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1997625194689831253) 2025-12-07T11:12Z 3009 followers, 1239 engagements "$COGT +0.54% today as Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048670038540369) 2025-12-08T15:14Z 3010 followers, XXX engagements "$BMEA Biomea Fusion presented P2 Type X Diabetes results on 2025-12-05 for Icovamenib More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141330975781344) 2025-12-08T21:23Z 3011 followers, XXX engagements "$PRTC PureTech presented P1 Acute Myeloid LeukemiaMyelodysplastic Syndrome results on 2025-12-05 for LYT-200 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141339876126724) 2025-12-08T21:23Z 3009 followers, XXX engagements "$XENE Xenon presented P3 Epilepsy results on 2025-12-06 for Azetukalner More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141349325942950) 2025-12-08T21:23Z 3010 followers, XXX engagements "🚀🚨 BIOPHARM CATALYST ALERT 📆 $LLY Eli Lilly will present Phase X Breast Cancer Data for Tersolisib (PI3K Inhibitor - Small Molecule) tomorrow 👀" [X Link](https://x.com/OzmosiHealth/status/1998350016369603026) 2025-12-09T11:12Z 3011 followers, XXX engagements "$ONC +1.67% today as BRUKINSA Delivers Landmark XX% 6-Year PFS in Patients with Treatment-Nave Chronic Lymphocytic Leukemia More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048643622850960) 2025-12-08T15:14Z 3011 followers, XXX engagements "$SNDX -XXXX% today as Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum More Info:" [X Link](https://x.com/OzmosiHealth/status/1998048675965055260) 2025-12-08T15:15Z 3009 followers, XXX engagements "$ALPMY Astellas Pharma presented P3 Acute Myeloid Leukemia results on 2025-12-06 for Gilteritinib More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141322041991496) 2025-12-08T21:23Z 3011 followers, XXX engagements "$STOK Stoke Therapeutics presented P1 Dravet Syndrome results on 2025-12-05 for Zorevunersen More Info:" [X Link](https://x.com/OzmosiHealth/status/1998141344615666047) 2025-12-08T21:23Z 3011 followers, XXX engagements "$LLY -XXXX% today as Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival reducing the risk of progression or death by XX% versus chemoimmunotherapy in patients with treatment-nave CLL/SLL More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422061853610059) 2025-12-09T15:58Z 3011 followers, XXX engagements "$MRK -XXXX% today as Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda (Pembrolizumab) in US and Canada More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422065884373236) 2025-12-09T15:58Z 3011 followers, XXX engagements "$GLMD Galmed announced they will present P1 Hepatocellular Carcinoma results on 2025-12-09 for Aramchol More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460081378091502) 2025-12-09T18:29Z 3011 followers, XXX engagements "$CASI CASI presented P1 Thrombocytopenia results on 2025-12-08 for CID-103 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460101779169704) 2025-12-09T18:29Z 3011 followers, XX engagements "$COGT Cogent Biosciences presented P2 Mastocytosis Systemic results on 2025-12-08 for Bezuclastinib More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460105969312079) 2025-12-09T18:29Z 3011 followers, XXX engagements "$GERN Geron presented P3 Myelodysplastic Syndrome results on 2025-12-08 for Imetelstat More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460144368185535) 2025-12-09T18:30Z 3011 followers, XX engagements "$RXRX Recursion Pharmaceuticals presented P2 Familial Adenomatous Polyposis results on 2025-12-08 for REC-4881 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998460179076026671) 2025-12-09T18:30Z 3011 followers, XXX engagements "$KYMR Kymera Therapeutics announced they will present P2 Dermatitis Atopic results in 3Q27 for KT-621 More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503152589361650) 2025-12-09T21:20Z 3011 followers, XX engagements "$DYN Dyne Therapeutics presented P1 Muscular Dystrophy Duchenne results on 2025-12-08 for Zeleciment rostudirsen More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503198491918364) 2025-12-09T21:21Z 3011 followers, XXX engagements "$RHHBY Hoffmann-La Roche presented P3 Diffuse Large B-Cell Lymphoma results on 2025-12-08 for Glofitamab More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503242347528660) 2025-12-09T21:21Z 3011 followers, XX engagements "$RHHBY Hoffmann-La Roche presented P3 Follicular Lymphoma results on 2025-12-08 for Mosunetuzumab More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503249280729191) 2025-12-09T21:21Z 3011 followers, XX engagements "$WVE Wave Life Sciences presented P1 Obesity results on 2025-12-08 for INHBE More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503313818435777) 2025-12-09T21:21Z 3011 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@OzmosiHealth Ozmosi
Ozmosi posts on X about more info, $kymr, kymera, $fate the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXX +92%
- X Month XXXXXXX -XX%
- X Months XXXXXXX +63%
- X Year XXXXXXXXX +37%
Mentions: XXX #
- X Week XXX +6.80%
- X Month XXX -XX%
- X Months XXXXX +25%
- X Year XXXXX +8.90%
Followers: XXXXX #
- X Week XXXXX +2%
- X Month XXXXX +3.50%
- X Months XXXXX +29%
- X Year XXXXX +48%
CreatorRank: XXXXXXX #
Social Influence
Social category influence stocks XXXX% cryptocurrencies X% countries XXX% currencies XXX% technology brands XXX%
Social topic influence more info #130, $kymr #30, kymera #10, $fate #1, $abbv #56, $rhhby #4, $biib #11, $gmab #3, $gern #2, $tern #9
Top accounts mentioned or mentioned by @saylor_monty @kdamokles
Top assets mentioned Kymera Therapeutics, Inc. Common Stock (KYMR) AbbVie Inc (ABBV) Biogen Inc (BIIB) Geron Corp (GERN) Terns Pharmaceuticals, Inc. Common Stock (TERN) CG Oncology, Inc. Common stock (CGON) AstraZeneca PLC (AZN) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Cogent Biosciences, Inc. Common Stock (COGT) Wave Life Sciences Ltd. Ordinary Shares (WVE) Neumora Therapeutics, Inc. Common Stock (NMRA) Taraxa (TARA) Dyne Therapeutics, Inc. Common Stock (DYN) Incyte Corporation (INCY) Arcellx, Inc. Common Stock (ACLX) Nuvalent, Inc. Class A Common Stock (NUVL) Dawn Protocol (DAWN) One Cash (ONC) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Disc Medicine, Inc. Common Stock (IRON) Arvinas, Inc (ARVN) Regeneron Pharmaceuticals Inc (REGN) Xenon Pharmaceuticals Inc (XENE) Merck & Co., Inc. (MRK) Eli Lilly and Company (LLY) Frontline Ltd. (FRO) BOLT Token (BOLT) Agios Pharmaceuticals, Inc. (AGIO) Praxis Precision Medicines, Inc. Common Stock (PRAX) Celldex Therapeutics, Inc (CLDX) Bristol-Myers Squibb Co (BMY) LYRA (LYRA) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Neurocrine Biosciences, Inc. (NBIX) Natera, Inc. Common Stock (NTRA) Jazz Pharmaceuticals, Inc. (JAZZ)
Top Social Posts
Top posts by engagements in the last XX hours
"$PHGE -XXXXX% today as BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review More Info:"
X Link 2025-12-08T15:14Z 3009 followers, XXX engagements
"$COYA +1.89% today as Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA XXX for the Treatment of ALS More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XX engagements
"$ENVB +2.04% today as Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$APVO -XXXX% today as Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025 More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$PDSB +17.13% today as PDS Biotech Announces New Composition of Matter Patent for PDS0101 in Japan More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$RHHBY Hoffmann-La Roche presented P3 Follicular Lymphoma results on 2025-12-08 for Mosunetuzumab More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XX engagements
"$KYMR Kymera Therapeutics presented P1 Dermatitis Atopic results on 2025-12-08 for KT-621 More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XX engagements
"$GPCR Structure Therapeutics presented P2 Obesity results on 2025-12-08 for Aleniglipron More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XXX engagements
"$OSTX +2.08% today as OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent Fully Resected Pulmonary Metastatic Osteosarcoma More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$FATE Fate presented P1 Lupus Erythematosus Systemic results on 2025-12-08 for FT-819 More Info:"
X Link 2025-12-09T18:29Z 3011 followers, XX engagements
"$CASI CASI presented P1 Thrombocytopenia results on 2025-12-08 for CID-103 More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$RXRX Recursion Pharmaceuticals presented P2 Familial Adenomatous Polyposis results on 2025-12-08 for REC-4881 More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements
"$RGNX Regenxbio announced they will present P3 Muscular Dystrophy Duchenne results in 2Q26 for Pivodisgene parvec More Info:"
X Link 2025-11-07T21:35Z 3010 followers, XXX engagements
"$RGNX Regenxbio announced they will present P3 Wet Macular Degeneration results in 4Q26 for Surabgene Lomparvovec More Info:"
X Link 2025-11-07T21:35Z 3010 followers, XXX engagements
"$BOLT Bolt Biotherapeutics announced they will present P1 AdenocarcinomaGastrointestinal CancerEsophageal Cancer results in 3Q26 for BDC-4182 More Info:"
X Link 2025-11-13T19:05Z 3009 followers, XXX engagements
"$4523 as Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status More Info:"
X Link 2025-11-25T14:54Z 3009 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $LEGN Legend Biotech will present Phase X Lymphoma Non-Hodgkin Data for Ciltacabtagene autoleucel (CAR-TBCMA - Autologous CAR-T) tomorrow 👀"
X Link 2025-12-05T11:12Z 3009 followers, XXX engagements
"$AGIO +0.87% today as Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia More Info:"
X Link 2025-12-08T15:15Z 3011 followers, XXX engagements
"$HRMY -XXXX% today as Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome More Info:"
X Link 2025-12-08T15:15Z 3011 followers, XXX engagements
"$ATOS +2.76% today as Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$AKTX -XXXX% today as Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate AKTX-101 for Hard-to-Treat K-Ras Mutant Pancreatic Cancer More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$PTIX -XXXX% today as Results from Phase X Multiple-Dose Study of PT00114 More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XX engagements
"$SNTI -XXXX% today as Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase X Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients Demonstrating Deep MRD Negative Durable Complete Remissions and a Favorable Safety Profile More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$ENSC -XXXXX% today as Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase X Trial of PF614 Its Next-Generation Opioid More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$KYMR Kymera Therapeutics announced they will present P2 Dermatitis Atopic results in 3Q27 for KT-621 More Info:"
X Link 2025-12-09T18:29Z 3011 followers, XX engagements
"$DYN Dyne Therapeutics presented P1 Muscular Dystrophy Duchenne results on 2025-12-08 for Zeleciment rostudirsen More Info:"
X Link 2025-12-09T18:29Z 3011 followers, XXX engagements
"$FATE Fate presented P0 Autoimmune Disease Unspecified results on 2025-12-08 for FT-839 More Info:"
X Link 2025-12-09T18:29Z 3011 followers, XX engagements
"$FATE Fate presented P0 Multiple Myeloma results on 2025-12-08 for FT-836 More Info:"
X Link 2025-12-09T18:29Z 3011 followers, XXX engagements
"$GMAB Genmab presented P1 Chronic Lymphoid Leukemia results on 2025-12-08 for Epcoritamab More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XX engagements
"$RHHBY Hoffmann-La Roche presented P3 Diffuse Large B-Cell Lymphoma results on 2025-12-08 for Glofitamab More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XX engagements
"$IVBIY Innovent presented P3 Psoriasis results on 2025-12-08 for Picankibart More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XX engagements
"$MNOV MediciNova presented P2 Amyotrophic Lateral Sclerosis results on 2025-12-08 for Ibudilast More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XX engagements
"$PRAX -XXXX% today as Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic Encephalopathy More Info:"
X Link 2025-12-09T21:20Z 3011 followers, XXX engagements
"$GLMD Galmed announced they will present P1 Hepatocellular Carcinoma results on 2025-12-09 for Aramchol More Info:"
X Link 2025-12-09T21:20Z 3011 followers, XXX engagements
"$AUTL Autolus Limited presented P1 Acute LeukemiaB-Cell Leukemia results on 2025-12-08 for Obecabtagene autoleucel More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements
"$COGT Cogent Biosciences presented P2 Mastocytosis Systemic results on 2025-12-08 for Bezuclastinib More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements
"$FATE Fate presented P0 Multiple Myeloma results on 2025-12-08 for FT-836 More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$FATE Fate presented P1 Lupus Erythematosus Systemic results on 2025-12-08 for FT-819 More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements
"$GLPG Galapagos presented P2 Mantle-Cell Lymphoma results on 2025-12-08 for GLPG-5101 More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$GMAB Genmab presented P1 Chronic Lymphoid Leukemia results on 2025-12-08 for Epcoritamab More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$INCY Incyte presented P1 Myeloproliferative Disorders results on 2025-12-08 for INCA-033989 More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$KYMR Kymera Therapeutics presented P1 Dermatitis Atopic results on 2025-12-08 for KT-621 More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$MNOV MediciNova presented P2 Amyotrophic Lateral Sclerosis results on 2025-12-08 for Ibudilast More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$NRIX Nurix Therapeutics presented P1 Waldenstrom Macroglobulinemia results on 2025-12-08 for Bexobrutideg More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements
"$GPCR Structure Therapeutics presented P2 Obesity results on 2025-12-08 for Aleniglipron More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements
"$SNDX Syndax presented P2 Acute Myeloid Leukemia results on 2025-12-08 for Revumenib More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements
"$FATE -XXXX% today as Fate Therapeutics Presents Updated Phase X Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs More Info:"
X Link 2025-12-08T15:14Z 3011 followers, XXX engagements
"$GERN +1.90% today as Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO (Imetelstat) in Lower-Risk MDS More Info:"
X Link 2025-12-08T15:15Z 3011 followers, XXX engagements
"$CHRS +8.16% today as Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma More Info:"
X Link 2025-12-08T15:15Z 3011 followers, XXX engagements
"$CRDF +10.61% today as Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 More Info:"
X Link 2025-12-08T21:22Z 3009 followers, XXX engagements
"$CLDX -XXXX% today as Celldex Initiates Global Registrational Phase X Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism More Info:"
X Link 2025-12-09T15:58Z 3009 followers, XX engagements
"$BMY -XXXX% today as BioNTech and Bristol Myers Squibb Present First Global Phase X Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$SNTI -XXXX% today as Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$AUTL Autolus Limited presented P1 Acute LeukemiaB-Cell Leukemia results on 2025-12-08 for Obecabtagene autoleucel More Info:"
X Link 2025-12-09T18:29Z 3011 followers, XXX engagements
"$CRVS Corvus presented P1 T-Cell Lymphoma results on 2025-12-08 for Soquelitinib More Info:"
X Link 2025-12-09T18:29Z 3011 followers, XXX engagements
"$CGEM Cullinan Oncology presented P1 Acute Myeloid LeukemiaMyelodysplastic Syndrome results on 2025-12-08 for CLN-049 More Info:"
X Link 2025-12-09T18:29Z 3011 followers, XXX engagements
"$GLPG Galapagos presented P2 Mantle-Cell Lymphoma results on 2025-12-08 for GLPG-5101 More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XX engagements
"$INCY Incyte presented P1 Myeloproliferative Disorders results on 2025-12-08 for INCA-033989 More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XX engagements
"$NRIX Nurix Therapeutics presented P1 Waldenstrom Macroglobulinemia results on 2025-12-08 for Bexobrutideg More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XX engagements
"$SABS SAb Biotherapeutics presented P1 Type X Diabetes results on 2025-12-08 for SAB-142 More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XX engagements
"$SNDX Syndax presented P2 Acute Myeloid Leukemia results on 2025-12-08 for Revumenib More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XXX engagements
"$TERN Terns presented P1 Chronic Myeloid Leukemia results on 2025-12-08 for TERN-701 More Info:"
X Link 2025-12-09T18:30Z 3009 followers, XXX engagements
"$WVE Wave Life Sciences presented P1 Obesity results on 2025-12-08 for INHBE More Info:"
X Link 2025-12-09T18:30Z 3009 followers, XXX engagements
"$CRVS Corvus presented P1 T-Cell Lymphoma results on 2025-12-08 for Soquelitinib More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements
"$CGEM Cullinan Oncology presented P1 Acute Myeloid LeukemiaMyelodysplastic Syndrome results on 2025-12-08 for CLN-049 More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$FATE Fate presented P0 Autoimmune Disease Unspecified results on 2025-12-08 for FT-839 More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$GERN Geron presented P3 Myelodysplastic Syndrome results on 2025-12-08 for Imetelstat More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$IVBIY Innovent presented P3 Psoriasis results on 2025-12-08 for Picankibart More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$SABS SAb Biotherapeutics presented P1 Type X Diabetes results on 2025-12-08 for SAB-142 More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements
"$TERN Terns presented P1 Chronic Myeloid Leukemia results on 2025-12-08 for TERN-701 More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements
"$BNR +1.06% today as Burning Rock's OncoGuide OncoScreen Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer More Info:"
X Link 2025-09-24T13:53Z 2990 followers, XXX engagements
"$LYRA Lyra Therapeutics announced they will present Phase X Sinusitis results on 2025-10-13 for Mometasone furoate More Info:"
X Link 2025-10-08T01:56Z 3004 followers, XXX engagements
"$FBIO -XXXX% today as Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics' Global Phase X Trials of Dotinurad for the Treatment of Gout More Info:"
X Link 2025-10-21T13:57Z 2984 followers, XXX engagements
"$ZLAB -XXXX% today as Zai Lab Announces Updated Phase X Data for Zocilurtatug Pelitecan (formerly ZL-1310) Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer and Initiation of Global Phase X Registrational Study More Info:"
X Link 2025-10-24T14:09Z 3011 followers, XXX engagements
"$IMAB I-Mab Biopharma presented P1 Gastrointestinal Cancer results on 2025-10-23 for Givastomig More Info:"
X Link 2025-10-24T14:09Z 3012 followers, XXX engagements
"$ARGX argenx announced they will present P2 Amyotrophic Lateral Sclerosis results in 1H26 for Adimanebart More Info:"
X Link 2025-11-03T15:09Z 2984 followers, XXX engagements
"$ARGX argenx announced they will present P3 Sjogren's Syndrome results in YE27 for Efgartigimod More Info:"
X Link 2025-11-03T15:09Z 2985 followers, XXX engagements
"$ACLX Arcellx announced they will present P2 Multiple Myeloma results on 2025-12-06 for Anitocabtagene autoleucel More Info:"
X Link 2025-11-04T20:55Z 2998 followers, XXX engagements
"$MLTX +3.95% today as MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody Sonelokimab More Info:"
X Link 2025-11-05T15:50Z 2984 followers, XXX engagements
"$ARGX -XXXX% today as argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada More Info:"
X Link 2025-11-05T15:50Z 2994 followers, XXX engagements
"$SCYX Scynexis announced they will present P2 Candidiasis results in YE26 for SCY-247 More Info:"
X Link 2025-11-06T20:26Z 2995 followers, XXX engagements
"$NMRA Neumora announced they will present P1 Alzheimer Disease results in 4Q25 for NMRA-511 More Info:"
X Link 2025-11-07T21:35Z 2994 followers, XXX engagements
"$NMRA Neumora announced they will present P1 Schizophrenia results in 4Q25 for NMRA-861 More Info:"
X Link 2025-11-07T21:35Z 2988 followers, XXX engagements
"$NMRA Neumora announced they will present P3 Depressive Disorder Major results in 1Q26 for Navacaprant More Info:"
X Link 2025-11-07T21:35Z 3009 followers, XXX engagements
"$ZLAB Zai Lab announced they will present P1 Dermatitis Atopic results in YE26 for ZL-1503 More Info:"
X Link 2025-11-07T21:35Z 3007 followers, XXX engagements
"$ZLAB Zai Lab announced they will present P1 Small Cell Lung Cancer results in 1H26 for Zocilurtatug pelitecan More Info:"
X Link 2025-11-07T21:35Z 2983 followers, XXX engagements
"$OTLK +29.95% today as Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD More Info:"
X Link 2025-11-13T16:01Z 2985 followers, XXX engagements
"$ASND +5.95% today as Results of Pivotal ApproaCH Trial of TransCon CNP (Navepegritide) in Children with Achondroplasia Published in JAMA Pediatrics More Info:"
X Link 2025-11-17T21:14Z 2984 followers, XXX engagements
"$CGON CG Oncology announced they will present P3 Bladder CancerMuscle Cancer results in 4Q25 for Cretostimogene grenadenorepvec More Info:"
X Link 2025-11-17T21:14Z 2988 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $NUVL Nuvalent will present Preclinical Brain CancerNon-Small-Cell Lung CancerOncology Solid Tumor UnspecifiedSmall Cell Lung Cancer Data for NVL-330 (ERBB2 InhibitorTK Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-11-18T11:12Z 2985 followers, XXX engagements
"$GMAB -XXXX% today as Genmab Announces EPKINLY (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma More Info:"
X Link 2025-11-18T17:31Z 3012 followers, XXX engagements
"$HRMY -XXXX% today as Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin X Receptor Agonist (BP1.15205) for Central Disorders of Hypersomnolence More Info:"
X Link 2025-11-19T14:57Z 2983 followers, XXX engagements
"$NBIX +0.55% today as Neurocrine Biosciences Announces Publication of Landmark Narrative Review on FDA-Approved VMAT2 Inhibitors Demonstrating Unique Profile of INGREZZA (valbenazine) Capsules More Info:"
X Link 2025-11-20T14:41Z 3011 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $DAWN Day One Biopharmaceuticals will present Phase X Glioma Data for Tovorafenib (RAFk Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-11-22T11:12Z 2990 followers, XXX engagements
"$DAWN +0.47% today as Day One Announces Three Year Follow-Up Data From OJEMDA (tovorafenib) Phase X FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting More Info:"
X Link 2025-11-24T14:58Z 2990 followers, XXX engagements
"$KYMR +0.24% today as Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader More Info:"
X Link 2025-11-25T14:54Z 2994 followers, XXX engagements
"$ANVS Annovis Bio announced they will present P3 Alzheimer Disease results on 2025-12-01 for Buntanetap More Info:"
X Link 2025-11-25T19:41Z 2984 followers, XXX engagements
"$CGON +4.52% today as CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting More Info:"
X Link 2025-11-25T21:20Z 2994 followers, XXX engagements
"$ONC +2.05% today as U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma More Info:"
X Link 2025-11-26T15:07Z 2995 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ANVS Annovis Bio will present Phase X Alzheimer Disease Data for Buntanetap (APP Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-11-30T11:12Z 3011 followers, XXX engagements
"$IONS -XXXX% today as Ionis receives U.S. FDA Breakthrough Therapy designation for olezarsen for severe hypertriglyceridemia (sHTG) More Info:"
X Link 2025-12-01T15:46Z 2983 followers, XXX engagements
"$HCM HUTCHMED announced they will present P2 Renal Cell Carcinoma results on 2025-12-05 for Fruquintinib More Info:"
X Link 2025-12-01T19:34Z 3004 followers, XXX engagements
"$HCM HUTCHMED announced they will present P3 ThrombocytopeniaPurpura Thrombocytopenic Idiopathic results on 2025-12-08 for Sovleplenib More Info:"
X Link 2025-12-01T19:34Z 3004 followers, XXX engagements
"$TARA -XXXX% today as Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase X ADVANCED-2 Trial of TARA-002 in BCG-Nave NMIBC Patients on Wednesday December X 2025 More Info:"
X Link 2025-12-01T22:15Z 2994 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $BIIB Biogen will present Phase X Healthy Volunteers Data for IONIS-MAPTRx (Tau Inhibitor - Nucleic Acid) tomorrow 👀"
X Link 2025-12-02T11:12Z 3002 followers, XXX engagements
"$IONS +0.20% today as Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD) More Info:"
X Link 2025-12-02T15:18Z 2983 followers, XXX engagements
"$CMND -XXXXX% today as Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder More Info:"
X Link 2025-12-02T15:18Z 2983 followers, XXX engagements
"$NTRA +1.76% today as Natera to Present XX Datasets Including 50000 Patients Featuring Signatera at the San Antonio Breast Cancer Symposium More Info:"
X Link 2025-12-02T15:18Z 2984 followers, XXX engagements
"$BIIB Biogen announced they will present P1 Dravet Syndrome results on 2025-12-05 for Zorevunersen More Info:"
X Link 2025-12-02T21:06Z 3003 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $TARA Protara Therapeutics will present Phase X Bladder CancerMuscle Cancer Data for TARA-002 (Cell TherapyIL12IL2IL6IL8IL10 - Cell Therapy) tomorrow 👀"
X Link 2025-12-03T11:12Z 2994 followers, XXX engagements
"$ABBV AbbVie announced they will present P1 Multiple Myeloma results on 2025-12-06 for Etentamig More Info:"
X Link 2025-12-03T20:59Z 3006 followers, XXX engagements
"$ABBV AbbVie announced they will present P2 Acute Myeloid Leukemia results on 2025-12-07 for Pivekimab sunirine More Info:"
X Link 2025-12-03T20:59Z 3005 followers, XXX engagements
"$ABBV AbbVie announced they will present P3 Myelodysplastic Syndrome results on 2025-12-06 for Venetoclax More Info:"
X Link 2025-12-03T20:59Z 3005 followers, XXX engagements
"$JAZZ Jazz announced they will present P3 Gastrointestinal Cancer results on 2026-01-09 for Zanidatamab More Info:"
X Link 2025-12-03T20:59Z 2983 followers, XXX engagements
"$BIIB Biogen presented P3 Alzheimer Disease results on 2025-12-02 for Lecanemab More Info:"
X Link 2025-12-03T20:59Z 3002 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $CGON CG Oncology will present Phase X Bladder Cancer Data for Cretostimogene grenadenorepvec (Gene TherapyGM-CSF - Gene Therapy) tomorrow 👀"
X Link 2025-12-04T11:12Z 3008 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $CGON CG Oncology will present Phase X Bladder Cancer Data for Cretostimogene grenadenorepvec (Gene TherapyGM-CSF - Gene Therapy) tomorrow 👀"
X Link 2025-12-04T11:12Z 3008 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $HCM HUTCHMED will present Phase X Renal Cell Carcinoma Data for Fruquintinib (VEGFR Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-04T11:12Z 3004 followers, XX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $BIIB Biogen will present Phase X Dravet Syndrome Data for Zorevunersen (Voltage-Gated Sodium Channel Modulator - Nucleic Acid) tomorrow 👀"
X Link 2025-12-04T11:12Z 3003 followers, XXX engagements
"$ENLV +0.91% today as Enlivex Management to Host Fireside Chat on December XX to Discuss RAIN Token Strategy and Allocetra Clinical Development More Info:"
X Link 2025-12-04T15:03Z 2984 followers, XXX engagements
"$ANVS Annovis Bio announced they will present Unknown Parkinson's Disease results on 2025-12-05 for Buntanetap More Info:"
X Link 2025-12-04T19:34Z 2998 followers, XXX engagements
"$KURA Kura Oncology announced they will present P3 Acute Myeloid Leukemia results on 2025-12-08 for Ziftomenib More Info:"
X Link 2025-12-04T19:34Z 3000 followers, XXX engagements
"$TARA Protara Therapeutics presented P2 Bladder CancerMuscle Cancer results on 2025-12-03 for TARA-002 More Info:"
X Link 2025-12-04T19:35Z 2994 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $IRON Disc Medicine will present Phase X AnemiaMyelofibrosis Data for DISC-0974 (HJV Antagonist - Antibody) tomorrow 👀"
X Link 2025-12-05T11:12Z 3011 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $IRON Disc Medicine will present Phase X Polycythemia Vera Data for DISC-3405 (TMPRSS6 Antagonist - Antibody) tomorrow 👀"
X Link 2025-12-05T11:12Z 3011 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ARVN Arvinas will present Preclinical Lymphoma Non-HodgkinLymphoma B-CellT-Cell Peripheral LymphomaImmunoblastic Lymphadenopathy Data for Zaloblideg (BCL6 Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-05T11:12Z 2995 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $GMAB Genmab will present Phase X Diffuse Large B-Cell Lymphoma Data for Epcoritamab (CD20 BinderCD3 Binder - Bispecific Antibody) tomorrow 👀"
X Link 2025-12-05T11:12Z 3010 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ACLX Arcellx will present Phase X Multiple Myeloma Data for Anitocabtagene autoleucel (CAR-TBCMA - Autologous CAR-T) tomorrow 👀"
X Link 2025-12-05T11:12Z 3011 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $GERN Geron will present Phase X Myelodysplastic Syndrome Data for Imetelstat (telomerase Inhibitor - Nucleic Acid) tomorrow 👀"
X Link 2025-12-05T11:12Z 3011 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $BEAM Beam Therapeutics will present Phase X Anemia Sickle Cell Data for BEAM-101 (Gene TherapyCD34 - Gene Therapy) tomorrow 👀"
X Link 2025-12-05T11:12Z 2983 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $NUVL Nuvalent will present Phase X Non-Small-Cell Lung Cancer Data for Zidesamtinib (ROS1 Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-05T11:12Z 3011 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ARVN Arvinas will present Preclinical Diffuse Large B-Cell Lymphoma Data for Zaloblideg (BCL6 Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-05T11:12Z 2998 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $REGN Regeneron will present Phase X Paroxysmal Nocturnal Hemoglobinuria Data for Pozelimab (C5 Inhibitor - Antibody) tomorrow 👀"
X Link 2025-12-05T11:12Z 2989 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $REGN Regeneron will present Phase X Diffuse Large B-Cell Lymphoma Data for Odronextamab (CD20 AntagonistCD3 Inhibitor - Bispecific Antibody) tomorrow 👀"
X Link 2025-12-05T11:12Z 2984 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $XENE Xenon will present Phase X Epilepsy Data for Azetukalner (KCNQ2 OpenerKCNQ3 Opener - Small Molecule) tomorrow 👀"
X Link 2025-12-05T11:12Z 2985 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ABBV AbbVie will present Phase X Multiple Myeloma Data for Etentamig (BCMA InhibitorCD3 Inhibitor - Bispecific Antibody) tomorrow 👀"
X Link 2025-12-05T11:12Z 3006 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ABBV AbbVie will present Phase X Myelodysplastic Syndrome Data for Venetoclax (BCL2 Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-05T11:12Z 3006 followers, XXX engagements
"$INTS Intensity announced they will present P2 Triple Negative Breast Cancer results on 2025-12-12 for INT230-6 More Info:"
X Link 2025-12-05T20:39Z 2982 followers, XXX engagements
"$PLRX Pliant presented P1 Oncology Solid Tumor Unspecified results on 2025-12-04 for PLN-101095 More Info:"
X Link 2025-12-05T20:39Z 3000 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $HCM HUTCHMED will present Phase X Oncology Solid Tumor Unspecified Data for HMPL-A83 (CD47 Inhibitor - Antibody) tomorrow 👀"
X Link 2025-12-06T11:12Z 2997 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $AZN AstraZeneca will present Phase X Acute Lymphoid Leukemia Data for Surovatamig (CD19 AntagonistCD3 Inhibitor - Bispecific Antibody) tomorrow 👀"
X Link 2025-12-06T11:12Z 2984 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $AZN AstraZeneca will present Phase X Lymphoma Non-Hodgkin Data for Surovatamig (CD19 AntagonistCD3 Inhibitor - Bispecific Antibody) tomorrow 👀"
X Link 2025-12-06T11:12Z 2984 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $AZN AstraZeneca will present Phase X Mantle-Cell Lymphoma Data for Acalabrutinib (Btk Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-06T11:12Z 3000 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $AZN AstraZeneca will present Phase X Oncology Hematological Unspecified Data for AZD-4512 (CD22 Inhibitor - Antibody Drug Conjugate) tomorrow 👀"
X Link 2025-12-06T11:12Z 2983 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $TERN Terns will present Phase X Chronic Myeloid Leukemia Data for TERN-701 (Bcr-Abl Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-07T11:12Z 3003 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $NVS Novartis will present Phase X Purpura Thrombocytopenic Idiopathic Data for Ianalumab (BLyS Inhibitor - Antibody) tomorrow 👀"
X Link 2025-12-08T11:12Z 3005 followers, XXX engagements
"$PRTC +4.81% today as PureTech Announces Successful End-of-Phase X Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis More Info:"
X Link 2025-12-08T15:14Z 3013 followers, XXX engagements
"$KYMR +50.38% today as Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis More Info:"
X Link 2025-12-08T15:14Z 3011 followers, XXX engagements
"$WVE +96.94% today as Wave Life Sciences Announces Positive Interim Data from Phase X INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss More Info:"
X Link 2025-12-08T15:14Z 3012 followers, XXX engagements
"$RXRX +0.43% today as Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks More Info:"
X Link 2025-12-08T15:14Z 3011 followers, XXX engagements
"$GPCR +174.36% today as Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist Aleniglipron More Info:"
X Link 2025-12-08T15:14Z 3011 followers, XXX engagements
"$NRIX +14.15% today as Nurix Therapeutics Presents New Data from the Phase X Trial of Bexobrutideg (NX-5948) in Waldenstrm Macroglobulinemia at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition More Info:"
X Link 2025-12-08T15:14Z 3011 followers, XXX engagements
"$RHHBY +1.50% today as Roche's Columvi combination shows sustained survival benefit at three-year follow up of pivotal phase III STARGLO study More Info:"
X Link 2025-12-08T15:14Z 3008 followers, XXX engagements
"$MBRX +4.57% today as Moleculin Announces New Annamycin Collaboration in Brain Tumors More Info:"
X Link 2025-12-08T15:14Z 3011 followers, XXX engagements
"$CASI -XXXX% today as CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting More Info:"
X Link 2025-12-08T15:15Z 3011 followers, XXX engagements
"$MRK -XXXX% today as Saskatchewan Adds CAPVAXIVE to Publicly Funded Adult Immunization Program More Info:"
X Link 2025-12-08T15:15Z 3011 followers, XXX engagements
"$MNOV -XXXX% today as MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND More Info:"
X Link 2025-12-08T15:15Z 3011 followers, XXX engagements
"$PCVX +1.36% today as Vaxcyte Doses First Participants in the OPUS Phase X Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults More Info:"
X Link 2025-12-08T15:15Z 3011 followers, XXX engagements
"$ZLAB -XXXX% today as Zai Lab Announces Dosing of First Participant in Global Phase 1/1b study of ZL-1503 an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis More Info:"
X Link 2025-12-08T15:15Z 3009 followers, XXX engagements
"$SABS -XXXX% today as SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management More Info:"
X Link 2025-12-08T15:15Z 3011 followers, XXX engagements
"$CGEM +17.66% today as Cullinan Therapeutics Showcases Compelling Clinical Data in AML for CLN-049 Novel FLT3xCD3 T Cell Engager in Oral Presentation at the 67th ASH Meeting More Info:"
X Link 2025-12-08T21:22Z 3011 followers, XXX engagements
"$CRVS -XXXX% today as Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial More Info:"
X Link 2025-12-08T21:23Z 3011 followers, XXX engagements
"$TERN +36.70% today as Terns Highlights Additional Positive Phase X Clinical Data Supporting TERN-701's Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting More Info:"
X Link 2025-12-08T21:23Z 3011 followers, XXX engagements
"$KYMR Kymera Therapeutics announced they will present P1 Dermatitis Atopic results on 2025-12-08 for KT-621 More Info:"
X Link 2025-12-08T21:23Z 3011 followers, XXX engagements
"$BIIB Biogen presented P1 Dravet Syndrome results on 2025-12-05 for Zorevunersen More Info:"
X Link 2025-12-08T21:23Z 3011 followers, XXX engagements
"$ORIC Oric presented P1 Non-Small-Cell Lung Cancer results on 2025-12-06 for Enozertinib More Info:"
X Link 2025-12-08T21:23Z 3011 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $ABBV AbbVie will present Phase X Acute Myeloid Leukemia Data for Pivekimab sunirine (CD123 Inhibitor - Antibody Drug Conjugate) tomorrow 👀"
X Link 2025-12-06T11:12Z 3009 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $KURA Kura Oncology will present Phase X Acute Myeloid Leukemia Data for Ziftomenib (MEN1 Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-07T11:12Z 3009 followers, 1239 engagements
"$COGT +0.54% today as Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) More Info:"
X Link 2025-12-08T15:14Z 3010 followers, XXX engagements
"$BMEA Biomea Fusion presented P2 Type X Diabetes results on 2025-12-05 for Icovamenib More Info:"
X Link 2025-12-08T21:23Z 3011 followers, XXX engagements
"$PRTC PureTech presented P1 Acute Myeloid LeukemiaMyelodysplastic Syndrome results on 2025-12-05 for LYT-200 More Info:"
X Link 2025-12-08T21:23Z 3009 followers, XXX engagements
"$XENE Xenon presented P3 Epilepsy results on 2025-12-06 for Azetukalner More Info:"
X Link 2025-12-08T21:23Z 3010 followers, XXX engagements
"🚀🚨 BIOPHARM CATALYST ALERT 📆 $LLY Eli Lilly will present Phase X Breast Cancer Data for Tersolisib (PI3K Inhibitor - Small Molecule) tomorrow 👀"
X Link 2025-12-09T11:12Z 3011 followers, XXX engagements
"$ONC +1.67% today as BRUKINSA Delivers Landmark XX% 6-Year PFS in Patients with Treatment-Nave Chronic Lymphocytic Leukemia More Info:"
X Link 2025-12-08T15:14Z 3011 followers, XXX engagements
"$SNDX -XXXX% today as Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum More Info:"
X Link 2025-12-08T15:15Z 3009 followers, XXX engagements
"$ALPMY Astellas Pharma presented P3 Acute Myeloid Leukemia results on 2025-12-06 for Gilteritinib More Info:"
X Link 2025-12-08T21:23Z 3011 followers, XXX engagements
"$STOK Stoke Therapeutics presented P1 Dravet Syndrome results on 2025-12-05 for Zorevunersen More Info:"
X Link 2025-12-08T21:23Z 3011 followers, XXX engagements
"$LLY -XXXX% today as Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival reducing the risk of progression or death by XX% versus chemoimmunotherapy in patients with treatment-nave CLL/SLL More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$MRK -XXXX% today as Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda (Pembrolizumab) in US and Canada More Info:"
X Link 2025-12-09T15:58Z 3011 followers, XXX engagements
"$GLMD Galmed announced they will present P1 Hepatocellular Carcinoma results on 2025-12-09 for Aramchol More Info:"
X Link 2025-12-09T18:29Z 3011 followers, XXX engagements
"$CASI CASI presented P1 Thrombocytopenia results on 2025-12-08 for CID-103 More Info:"
X Link 2025-12-09T18:29Z 3011 followers, XX engagements
"$COGT Cogent Biosciences presented P2 Mastocytosis Systemic results on 2025-12-08 for Bezuclastinib More Info:"
X Link 2025-12-09T18:29Z 3011 followers, XXX engagements
"$GERN Geron presented P3 Myelodysplastic Syndrome results on 2025-12-08 for Imetelstat More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XX engagements
"$RXRX Recursion Pharmaceuticals presented P2 Familial Adenomatous Polyposis results on 2025-12-08 for REC-4881 More Info:"
X Link 2025-12-09T18:30Z 3011 followers, XXX engagements
"$KYMR Kymera Therapeutics announced they will present P2 Dermatitis Atopic results in 3Q27 for KT-621 More Info:"
X Link 2025-12-09T21:20Z 3011 followers, XX engagements
"$DYN Dyne Therapeutics presented P1 Muscular Dystrophy Duchenne results on 2025-12-08 for Zeleciment rostudirsen More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements
"$RHHBY Hoffmann-La Roche presented P3 Diffuse Large B-Cell Lymphoma results on 2025-12-08 for Glofitamab More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$RHHBY Hoffmann-La Roche presented P3 Follicular Lymphoma results on 2025-12-08 for Mosunetuzumab More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XX engagements
"$WVE Wave Life Sciences presented P1 Obesity results on 2025-12-08 for INHBE More Info:"
X Link 2025-12-09T21:21Z 3011 followers, XXX engagements